ELIXIR PHARMACEUTICALS

Elixir Pharmaceuticals is a pharmaceutical company focused on the discovery, development and commercialization of novel pharmaceuticals for the treatment of metabolic diseases such as diabetes and obesity. The Company's scientific founders identified that interactions between specific genes and enzymes can slow the aging process, and they are developing compounds that stimulate these interactions and will be used to treat a range of diseases of aging, including metabolic disease.

#People #Financial #Website #More

ELIXIR PHARMACEUTICALS

Industry:

Biotechnology Diabetes Pharmaceutical

Founded:

1999-01-01

Address:

Cambridge, Massachusetts, United States

Country:

United States

Website Url:

http://www.elixirpharm.com

Total Employee:

11+

Status:

Closed

Contact:

617-995-7000

Email Addresses:

[email protected]

Total Funding:

98.5 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible Nginx DigiCert SSL CloudFront Google Adsense AdBlock Acceptable Ads Hetzner Google Adsense For Domains Thawte SSL

Founder

lenny-guarente_image

Lenny Guarente

Investors List

omega-funds_image

Omega Funds

Omega Funds investment in Series D - Elixir Pharmaceuticals

physic-ventures_image

Physic Ventures

Physic Ventures investment in Series D - Elixir Pharmaceuticals

arch-venture-partners_image

ARCH Venture Partners

ARCH Venture Partners investment in Series D - Elixir Pharmaceuticals

oxford-bioscience-partners_image

Oxford Bioscience Partners

Oxford Bioscience Partners investment in Series D - Elixir Pharmaceuticals

mpm-capital_image

MPM Capital

MPM Capital investment in Series D - Elixir Pharmaceuticals

herculescapital_image

Hercules Capital

Hercules Capital investment in Series C - Elixir Pharmaceuticals

yfy-biotech-management-company_image

YFY Biotech Management Company

YFY Biotech Management Company investment in Series C - Elixir Pharmaceuticals

herculescapital_image

Hercules Capital

Hercules Capital investment in Debt Financing - Elixir Pharmaceuticals

arch-venture-partners_image

ARCH Venture Partners

ARCH Venture Partners investment in Series C - Elixir Pharmaceuticals

oxford-bioscience-partners_image

Oxford Bioscience Partners

Oxford Bioscience Partners investment in Series C - Elixir Pharmaceuticals

Official Site Inspections

http://www.elixirpharm.com

Host Informations
Whois Informations

Loading ...

More informations about "Elixir Pharmaceuticals" on Search Engine